StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hualan Biological Engineering Inc.
Shenzhen Stock Exchange:002007.SZ
Sector
Location
Market Cap
USD 4.03 B
Share Price
USD 2.21
Avg Daily Volume
13,009,053
Change (1 day)
0.27%
Change (1 year)
7.42%
Change (YTD)
-4.23%
Hualan Biological Engineering Inc. Capital Expenditure for the year ending December 31, 2024: USD -35.03 M
Hualan Biological Engineering Inc. Capital Expenditure is USD -35.03 M for the year ending December 31, 2024, a -66.99% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
-
Hualan Biological Engineering Inc. Capital Expenditure for the year ending December 31, 2023 was USD -106.12 M, a 85.89% change year over year.
-
Hualan Biological Engineering Inc. Capital Expenditure for the year ending December 31, 2022 was USD -57.09 M, a -55.29% change year over year.
-
Hualan Biological Engineering Inc. Capital Expenditure for the year ending December 31, 2021 was USD -127.69 M, a 34.12% change year over year.
-
Hualan Biological Engineering Inc. Capital Expenditure for the year ending December 31, 2020 was USD -95.20 M, a 142.90% change year over year.
Competitors
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Moderna, Inc.
USD 32.54
MRNA
+2.64
8.83%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.02
0.21%
Swedish Orphan Biovitrum AB (publ)
USD 29.81
SOBI.ST
-0.05
-0.16%
Ionis Pharmaceuticals, Inc.
USD 41.34
IONS
-0.44
-1.05%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.77
300122.SZ
+0.06
2.12%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.13
1877.HK
+0.03
1.05%
Vaxcyte, Inc.
USD 33.46
PCVX
+1.46
4.56%
Rhythm Pharmaceuticals, Inc.
USD 65.14
RYTM
-1.25
-1.88%
Apogee Therapeutics, Inc.
USD 36.41
APGE
-2.83
-7.21%
Apellis Pharmaceuticals, Inc.
USD 17.89
APLS
+0.47
2.70%
NewAmsterdam Pharma Company N.V.
USD 20.02
NAMS
+0.56
2.88%
Ligand Pharmaceuticals Incorporated
USD 115.12
LGND
+1.36
1.20%
Bavarian Nordic A/S
USD 27.02
BAVA.CO
+0.46
1.72%
Adaptive Biotechnologies Corporation
USD 11.74
ADPT
0.00%
ARS Pharmaceuticals, Inc.
USD 16.95
SPRY
-0.14
-0.82%
Immunocore Holdings plc
USD 33.28
IMCR
+0.87
2.68%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Key Data
| Date | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Depreciation And Amortization |
|---|
Competitors
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Moderna, Inc.
USD 32.54
MRNA
+2.64
8.83%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.02
0.21%
Swedish Orphan Biovitrum AB (publ)
USD 29.81
SOBI.ST
-0.05
-0.16%
Ionis Pharmaceuticals, Inc.
USD 41.34
IONS
-0.44
-1.05%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.77
300122.SZ
+0.06
2.12%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.13
1877.HK
+0.03
1.05%
Vaxcyte, Inc.
USD 33.46
PCVX
+1.46
4.56%
Rhythm Pharmaceuticals, Inc.
USD 65.14
RYTM
-1.25
-1.88%
Apogee Therapeutics, Inc.
USD 36.41
APGE
-2.83
-7.21%
Apellis Pharmaceuticals, Inc.
USD 17.89
APLS
+0.47
2.70%
NewAmsterdam Pharma Company N.V.
USD 20.02
NAMS
+0.56
2.88%
Ligand Pharmaceuticals Incorporated
USD 115.12
LGND
+1.36
1.20%
Bavarian Nordic A/S
USD 27.02
BAVA.CO
+0.46
1.72%
Adaptive Biotechnologies Corporation
USD 11.74
ADPT
0.00%
ARS Pharmaceuticals, Inc.
USD 16.95
SPRY
-0.14
-0.82%
Immunocore Holdings plc
USD 33.28
IMCR
+0.87
2.68%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%